NSE/EPIGRAL

EPIGRALEPIGRAL

NSE Equity · NSE

₹1,201.05-0.62%

52-wk low52-WEEK RANGE52-wk high

₹810.45+48.2% from low ·-42.5% from high₹2,088.7

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

EPIGRAL-28.47% · 1Y

Range high ₹2,114Range low ₹807Latest ₹1,201.05252 bars · daily-close · NSE bhavcopy + 10Y history

NSE EquityChemicalsSmallcapLow Risk

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite50/100

Performance

Low

Hasn't fared well — amongst the weak performers.

· 52w return -36.7% — underperformer
· Below 200-DMA (-18.8%) — downtrend

Valuation

Low

Appears to be fairly valued to cheap vs peers.

· P/E 14.9 vs sector median 24.8 — 40% cheaper

Growth

—

Not enough historical data.

Profitability

Medium

Average profitability vs peers.

· ROE 16.1%
· Top quartile ROE in Other

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeB(63/100)

Durability

A+

85/100

Financially resilient — strong quality + solvency profile.

Show 2 drivers

Debt/Equity0.26 (100pt)
ROE16.1% (64pt)

Valuation

70/100

Fairly priced — not a bargain, not stretched.

Show 4 drivers

P/E vs sector (14.9 / 24.8)60% (100pt)
P/B2.40 (40pt)
Dividend yield0.92% (23pt)
EV/EBITDA10.4 (70pt)

Momentum

35/100

Momentum is muted; trend is unclear or rolling over.

Show 5 drivers

52w change-36.7% (0pt)
DMA-trend alignmentsideways (50pt)
RSI (14)78.2 (65pt)
Price vs 200-DMA-16.4% (27pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)14.92

UNDERVALUED

CheapestP/E 14.9 at 19th %ile of sector — cheaper than 81% of peers.Most expensive

P/B2.40

FAIR

CheapestP/B 2.40 at 47th %ile of sector.Most expensive

EV/EBITDA10.41

FAIR

Monthly seasonality

Avg monthly return over 3 years · historical — not a forecast

Best: Jul +20.94% · Worst: Dec -6.76%

Jan

-3.5%

33% win

Feb

-4.6%

33% win

Mar

+0.7%

33% win

Apr

+20.0%

67% win

May

-2.7%

50% win

Jun

+5.1%

Monthly return distribution

Distribution of 32 monthly returns

Mean

+1.50%

Median

-1.45%

Std dev

14.50%

Best

+48.2%

Worst

-19.3%

% positive

44%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 2

Lean balance sheet (D/E 0.26)
Low leverage means earnings are less sensitive to rate cycles
Top quartile ROE in Other
Rank 198 of 1000 peers

WEAKNESSES · 0

No material weaknesses flag from the numbers

OPPORTUNITIES · 1

71% upside to consensus target (₹2000)
1 analysts see fair value materially higher

THREATS · 1

RSI overbought at 78
Above 75 often precedes consolidation or short-term pullbacks

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

-0.6%

+9.4%

+37.8%

+5.5%

-30.6%

-30.0%

+7.0%

10Y

—

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
EPIGRALTHIS Epigral Limited	₹1,201.05	-36.7%	5,041	14.9	2.40	16.1%	0.26	—
ABCAPITAL Aditya Birla Capital Limited	₹340.4	+68.1%	89,888	25.8	2.79	10.8%	4.60	+17.6%
ABBOTINDIA Abbott India Limited	₹25,785	-16.6%	54,547	35.8	13.60	38.0%	0.04	+9.6%
360ONE 360 ONE WAM LIMITED	₹1,113.3	+16.7%	44,744	38.7	4.77	12.3%	1.47	+35.0%
3MINDIA 3M India Limited	₹31,410	+4.4%	35,158	92.9	21.83	23.5%	0.06	+6.1%
AADHARHFC Aadhar Housing Finance Limited	₹496.45	+3.5%	21,173	20.8	3.05	14.6%	2.55	—
ABDL Allied Blenders and Distillers Limited	₹573.8	+76.4%	16,176	60.4	10.70	17.7%	0.67	+5.8%
AAVAS Aavas Financiers Limited	₹1,347.9	-37.8%	10,612	17.1	2.26	13.3%	3.08	+13.3%
63MOONS 63 moons technologies limited	₹662.7	-9.8%	8,006	—	0.92	-0.2%	0.00	-6.3%

ASK AXEL

Dig deeper into EPIGRAL

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for EPIGRAL — all in one sourced reply.

Ask free in chat

Run these tools on EPIGRAL

Historical return →

"If I had bought EPIGRAL in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on EPIGRAL

Brokerage + charges →

All-in cost for trading EPIGRAL

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Quarter	EPS estimate	EPS actual	Surprise %
-1q	14.10	11.87	-15.8%
-2q	18.80	37.25	+98.1%
-3q	20.30	20.14	-0.8%
-4q	19.40	24.25	+25.0%

Date	Amount
2025-06-20	₹3.50
2025-02-07	₹2.50
2024-07-02	₹5.00

EPIGRALEPIGRAL

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Analyst consensus

Company + balance sheet snapshot

Peer comparison · Other

Ask Axel about EPIGRAL

Recent news

Dig deeper into EPIGRAL

Run these tools on EPIGRAL

Technical snapshot

Earnings history + surprises

Dividends + splits history

Stock scorecard

SWOT analysis

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Recent news

Fundamentals

Pros and cons

Sector-relative context

Analyst consensus

Company + balance sheet snapshot

Peer comparison · Other